glp-1 shortages New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although ended in 2025, some facilities may still be producing these drugs at scale. Our The GLP-1 drug shortage is

Pulmonary arterial hypertension patients have a proinflammatory gut microbiome and altered circulating microbial metabolites

The ECAR and OCR were then measured as recommended by Seahorse Bioscience

In early studies, the addition of oral L-carnitine or propionyl-L-carnitine to pharmacologic therapy for chronic stable angina modestly improved exercise tolerance and decreased electrocardiographic signs of ischemia during exercise testing in some angina patients (59-61)

In research contexts, L-Glutathione has been investigated for its role in maintaining intracellular redox balance through reversible oxidation-reduction cycling between the reduced form (GSH) and oxidized form (GSSG)